Role of Exercise Training on Autonomic Changes and Inflammatory Profile Induced by Myocardial Infarction

Imagem de Miniatura
Arquivos
art_RODRIGUES_Role_of_Exercise_Training_on_Autonomic_Changes_and_2014.PDF (3.11 MB)
Citações na Scopus
23
Tipo de produção
article
Data de publicação
2014
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
HINDAWI PUBLISHING CORPORATION
Autores
RODRIGUES, Bruno
LIRA, Fabio S.
CAPERUTO, Erico C.
ANGELIS, Katia De
Citação
MEDIATORS OF INFLAMMATION, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The cardiovascular autonomic imbalance in patients after myocardial infarction (MI) provides a significant increase in mortality rate, and seems to precede metabolic, hormonal, and immunological changes. Moreover, the reduction in the parasympathetic function has been associated with inflammatory response in different pathological conditions. Over the years, most of the studies have indicated the exercise training (ET) as an important nonpharmacological tool in the management of autonomic dysfunction and reduction in inflammatory profile after a myocardial infarction. In this work, we reviewed the effects of ET on autonomic imbalance after MI, and its consequences, particularly, in the post-MI inflammatory profile. Clinical and experimental evidence regarding relationship between alterations in autonomic regulation and local or systemic inflammation response after MI were also discussed.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/7819
Referências
  1. Adamopoulos S, 2002, J AM COLL CARDIOL, V39, P653, DOI 10.1016/S0735-1097(01)01795-8
  2. Adamopoulos S, 2001, EUR HEART J, V22, P791, DOI 10.1053/euhj.2000.2285
  3. Ammirati E, 2012, CIRC RES, V111, P1336, DOI 10.1161/CIRCRESAHA.111.262477
  4. Anker SD, 1999, EUR HEART J, V20, P683, DOI 10.1053/euhj.1998.1446
  5. Aronson D, 2001, J CARDIOVASC ELECTR, V12, P294, DOI 10.1046/j.1540-8167.2001.00294.x
  6. Bachetti T, 1998, EUR HEART J, V19, P681
  7. Barboza CA, 2013, EUR J APPL PHYSIOL, V113, P1137, DOI 10.1007/s00421-012-2533-3
  8. Batista ML, 2010, CYTOKINE, V49, P102, DOI 10.1016/j.cyto.2009.10.007
  9. Ben Ounis O, 2009, ANN ENDOCRINOL-PARIS, V70, P235, DOI 10.1016/j.ando.2009.03.003
  10. BILLMAN GE, 1984, CIRCULATION, V69, P1182
  11. Blalock JE, 2005, J INTERN MED, V257, P126, DOI 10.1111/j.1365-2796.2004.01441.x
  12. Borovikova LV, 2000, NATURE, V405, P458
  13. Braga LMGD, 2008, CLIN EXP PHARMACOL P, V35, P113, DOI 10.1111/j.1440-1681.2007.04820.x
  14. Braga LMGD, 2008, J BIOMED SCI, V15, P365, DOI 10.1007/s11373-008-9237-z
  15. BRANDAO MUP, 1993, J APPL PHYSIOL, V75, P1989
  16. Brandt C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/520258
  17. Braunwald E, 2000, CIRCULATION, V102, P14
  18. Brum PC, 2000, HYPERTENSION, V36, P1018
  19. Conraads VM, 2002, EUR HEART J, V23, P1854, DOI 10.1053/euhj.2002.3239
  20. D'Andrea Antonello, 2002, Ital Heart J, V3, P34
  21. DART AM, 1992, CLIN EXP PHARMACOL P, V19, P777, DOI 10.1111/j.1440-1681.1992.tb00415.x
  22. De Angelis K, 2004, J APPL PHYSIOL, V96, P2174, DOI 10.1152/japplphysiol.00870.2003
  23. de La Fuente RN, 2013, CLIN EXP PHARMACOL P, V40, P610, DOI 10.1111/1440-1681.12121
  24. Diwan A, 2003, CURR MOL MED, V3, P161, DOI 10.2174/1566524033361537
  25. ECKBERG DL, 1971, NEW ENGL J MED, V285, P877, DOI 10.1056/NEJM197110142851602
  26. Ertek S, 2012, ARCH MED SCI, V8, P794, DOI 10.5114/aoms.2012.31614
  27. Favret F, 2001, J APPL PHYSIOL, V91, P1283
  28. Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev
  29. Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061
  30. Floras JS, 2003, ACTA PHYSIOL SCAND, V177, P391, DOI 10.1046/j.1365-201X.2003.01087.x
  31. Flores LJ, 2010, MENOPAUSE, V17, P712, DOI 10.1097/gme.0b013e3181cdebc9
  32. Flynn MG, 2006, EXERC SPORT SCI REV, V34, P176, DOI 10.1249/01.jes.0000240027.22749.14
  33. Francis J, 2004, AM J PHYSIOL-HEART C, V286, pH2264, DOI 10.1152/ajpheart.01072.2003
  34. Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041
  35. Gleeson M, 2006, EXERC IMMUNOL REV, V12, P34
  36. Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80
  37. GRANS CF, ARQUIVOS BR IN PRESS
  38. Hasper D, 1998, EUR HEART J, V19, P761, DOI 10.1053/euhj.1997.0858
  39. HULL SS, 1994, CIRCULATION, V89, P548
  40. Huston JM, 2011, J INTERN MED, V269, P45, DOI 10.1111/j.1365-2796.2010.02321.x
  41. Iellamo F, 2000, CIRCULATION, V102, P2588
  42. Jankowska EA, 2006, CARDIOVASC RES, V70, P434, DOI 10.1016/j.cardiores.2006.01.013
  43. Jorge L, 2011, EUR HEART J, V32, P904, DOI 10.1093/eurheartj/ehq244
  44. Kawanishi N, 2010, EXERC IMMUNOL REV, V16, P105
  45. Kishi T, 2004, CIRCULATION, V109, P2357, DOI 10.1161/01.CIR.0000128695.49900.12
  46. Kishi T, 2010, HYPERTENSION, V55, P291, DOI 10.1161/HYPERTENSIONAHA.109.138636
  47. KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8
  48. Lacerda JED, 2007, AUTON NEUROSCI-BASIC, V133, P128, DOI 10.1016/j.autneu.2006.10.009
  49. Lakka TA, 2007, APPL PHYSIOL NUTR ME, V32, P76, DOI 10.1139/H06-113
  50. Lancaster GI, 2005, J PHYSIOL-LONDON, V563, P945, DOI 10.1116/jphysiol.2004.081224
  51. Lanza GA, 2006, AM J CARDIOL, V97, P1702, DOI 10.1016/j.amjcard.2006.01.029
  52. La Rovere MT, 2002, CIRCULATION, V106, P945, DOI 10.1161/01.CIR.00000237565.12764.E1
  53. LAROVERE MT, 1992, CHEST, V101, pS299, DOI 10.1378/chest.101.5_Supplement.299S
  54. La Rovere MT, 1998, LANCET, V351, P478
  55. Lawler PR, 2011, AM HEART J, V162, P571, DOI 10.1016/j.ahj.2011.07.017
  56. Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA
  57. Lim S, 2008, J CLIN ENDOCR METAB, V93, P2263, DOI 10.1210/jc.2007-2028
  58. Malfatto G, 1996, EUR HEART J, V17, P532
  59. Malfitano C, 2010, EUR J HEART FAIL, V12, P659, DOI 10.1093/eurjhf/hfq053
  60. Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B
  61. Mann N, 2012, CIRCULATION, V126, P2625, DOI 10.1161/CIRCULATIONAHA.111.060376
  62. Martinez DG, 2011, HYPERTENSION, V58, P1049, DOI 10.1161/HYPERTENSIONAHA.111.176644
  63. Mathur N, 2008, MEDIAT INFLAMM, DOI 10.1155/2008/109502
  64. Meldrum DR, 1998, AM J PHYSIOL-REG I, V274, pR577
  65. Mostarda C, 2010, CLIN EXP PHARMACOL P, V37, P447, DOI 10.1111/j.1440-1681.2009.05327.x
  66. Mujumdar PP, 2011, SCAND J CLIN LAB INV, V71, P101, DOI 10.3109/00365513.2011.554995
  67. Muller-Werdan U, 2000, HERZ, V25, P271, DOI 10.1007/s000590050019
  68. Negrao CE, 2008, HEART FAIL REV, V13, P51, DOI 10.1007/s10741-007-9057-7
  69. Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa
  70. Niebauer J, 1999, LANCET, V353, P1838, DOI 10.1016/S0140-6736(98)09286-1
  71. Nunes RB, 2013, CLINICS, V68, P876, DOI 10.6061/clinics/2013(06)24
  72. Ogawa K, 2011, J CARDIOVASC PHARM, V58, P543, DOI 10.1097/FJC.0b013e31822e6b40
  73. Ono K, 1998, CIRCULATION, V98, P149
  74. Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101
  75. Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103
  76. Pedersen BK, 2000, PHYSIOL REV, V80, P1055
  77. Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x
  78. Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007
  79. Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004
  80. Ponikowski P, 2001, CIRCULATION, V104, P544, DOI 10.1161/hc3101.093699
  81. Ponikowski PP, 2001, CIRCULATION, V104, P2324, DOI 10.1161/hc4401.098491
  82. Pretolani M, 1999, CLIN EXP ALLERGY, V29, P1164, DOI 10.1046/j.1365-2222.1999.00456.x
  83. Rangwala F, 1997, J NEUROSCI, V17, P8201
  84. Rodrigues B, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-26
  85. Rodrigues B, 2012, J CARD FAIL, V18, P734, DOI 10.1016/j.cardfail.2012.07.006
  86. Rodrigues B, 2011, CLINICS, V66, P1437, DOI 10.1590/S1807-59322011000800022
  87. RODRIGUES B, 2011, J DIABETES METABOLIS, V4
  88. Rodrigues B, 2013, J DIABETES COMPLICAT, V27, P16, DOI 10.1016/j.jdiacomp.2012.08.002
  89. Rondon E, 2006, AM J PHYSIOL-HEART C, V291, pH2801, DOI 10.1152/ajpheart.01352.2005
  90. Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039
  91. Sandercock GRH, 2007, CLIN AUTON RES, V17, P39, DOI 10.1007/s10286-007-0392-5
  92. SCHINDLER R, 1990, BLOOD, V75, P40
  93. SHAPIRO LM, 1983, BRIT HEART J, V50, P534
  94. Sharma R, 2000, INT J CARDIOL, V72, P175, DOI 10.1016/S0167-5273(99)00186-2
  95. SHISHEHBOR MH, 2007, CLEV CLIN J MED, V74, P37
  96. Sloan RP, 2007, MOL MED, V13, P178, DOI 10.2119/2006-00112.Sloan
  97. Smith JK, 1999, JAMA-J AM MED ASSOC, V281, P1722, DOI 10.1001/jama.281.18.1722
  98. SMITH ML, 1989, MED SCI SPORT EXER, V21, P40, DOI 10.1249/00005768-198902000-00008
  99. Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003
  100. Suzuki K, 2002, EXERC IMMUNOL REV, V8, P6
  101. Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009
  102. Thiene G, 2010, CARDIOVASC PATHOL, V19, P1, DOI 10.1016/j.carpath.2009.08.002
  103. Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058
  104. TorreAmione G, 1996, CIRCULATION, V93, P704
  105. Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566
  106. Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321
  107. Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555
  108. Tsutsumi T, 2008, CARDIOVASC RES, V77, P713, DOI 10.1093/cvr/cvm092
  109. Walsh NP, 2011, EXERC IMMUNOL REV, V17, P6
  110. Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124
  111. Yudkin JS, 2007, HORM METAB RES, V39, P707, DOI 10.1055/s-2007-985898
  112. Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968
  113. Zucker IH, 2009, AM J PHYSIOL-HEART C, V297, pH1557, DOI 10.1152/ajpheart.00073.2009

Coleções
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/59